1-4 of 4
Behrouz Mansouri Taleghani, MD
Close
Sort by
Journal Articles

Stem Cell Mobilization Chemotherapy with Gemcitabine Is Effective and Safe in Myeloma Patients with Bortezomib Induced Neurotoxicity

Beatrice U. Mueller, MD, Sandra Keller, MD, Katja Seipel, PhD, Behrouz Mansouri Taleghani, MD, Thomas Pabst, MD
Journal: Blood
Blood (2015) 126 (23): 5436.
https://doi.org/10.1182/blood.V126.23.5436.5436
Published: 2015
Journal Articles

Transfusion Efficacy of Apheresis Platelet Concentrates (APCs) Irradiated in Advance Is Significantly Lower Compared to Products Irradiated within 24 hours Before Transfusion.

Friedgard Julmy, MT, Roland A Ammann, MD, Behrouz Mansouri Taleghani, MD, Stefano Fontana, MD, Andreas Hirt, MD, Kurt Leibundgut, MD
Journal: Blood
Blood (2009) 114 (22): 3139.
https://doi.org/10.1182/blood.V114.22.3139.3139
Published: 2009
Journal Articles

Apart from Blood Group A2, ABO Antigen Incompatible Platelet Transfusions Result in Significantly Lower Corrected Count Increments (CCI) in Children.

Friedgard Julmy, MT, Behrouz Mansouri Taleghani, MD, Roland A. Ammann, MD, Stefano Fontana, MD, Kurt Leibundgut, MD
Journal: Blood
Blood (2006) 108 (11): 579.
https://doi.org/10.1182/blood.V108.11.579.579
Published: 2006
Journal Articles

Transfusion Effectiveness of Single-Donor Apheresis Platelets Depends on Apheresis Device and Platelet Yield: Results of a Prospective Study in Children.

Friedgard Julmy, MT, Roland A. Ammann, MD, Stefano Fontana, MD, Behrouz Mansouri Taleghani, MD, Kurt E. Leibundgut, MD
Journal: Blood
Blood (2005) 106 (11): 951.
https://doi.org/10.1182/blood.V106.11.951.951
Published: 2005